Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | ATPase | 0.0748 | 0.5782 | 0.5 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.1186 | 0.9459 | 1 |
Loa Loa (eye worm) | VCP protein | 0.0517 | 0.3839 | 0.6788 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0748 | 0.5782 | 0.5 |
Trypanosoma brucei | Valosin-containing protein | 0.1186 | 0.9459 | 1 |
Brugia malayi | ATPase, AAA family protein | 0.0064 | 0.0035 | 0.0062 |
Toxoplasma gondii | transitional endoplasmic reticulum ATPase, putative | 0.0748 | 0.5781 | 0.5767 |
Brugia malayi | fidgetin protein | 0.0064 | 0.0035 | 0.0062 |
Trypanosoma cruzi | vacuolar transport protein 4A, putative | 0.0064 | 0.0035 | 0.0000043848 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.1186 | 0.9459 | 0.9457 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.125 | 1 | 1 |
Giardia lamblia | AAA family ATPase | 0.0748 | 0.5782 | 1 |
Loa Loa (eye worm) | ATPase | 0.0064 | 0.0035 | 0.0062 |
Brugia malayi | vps4b-prov protein | 0.0064 | 0.0035 | 0.0062 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0748 | 0.5782 | 0.5767 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.1186 | 0.9459 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.125 | 1 | 1 |
Brugia malayi | valosin containing protein | 0.0733 | 0.5655 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0517 | 0.3839 | 0.3817 |
Brugia malayi | transitional endoplasmic reticulum ATPase TER94, putative | 0.0517 | 0.3839 | 0.6788 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.125 | 1 | 1 |
Trypanosoma cruzi | katanin, putative | 0.0064 | 0.0035 | 0.0000043848 |
Loa Loa (eye worm) | hypothetical protein | 0.0733 | 0.5655 | 1 |
Trypanosoma cruzi | katanin-like protein, putative | 0.0064 | 0.0035 | 0.0000043848 |
Trypanosoma cruzi | katanin, putative | 0.0064 | 0.0035 | 0.0000043848 |
Trypanosoma cruzi | katanin, putative | 0.0064 | 0.0035 | 0.0000043848 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.1186 | 0.9459 | 1 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.125 | 1 | 0.5 |
Trichomonas vaginalis | proteasome-activating nucleotidase, putative | 0.0295 | 0.1978 | 0.195 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.1186 | 0.9459 | 1 |
Loa Loa (eye worm) | fidgetin protein | 0.0064 | 0.0035 | 0.0062 |
Entamoeba histolytica | cdc48-like protein, putative | 0.1186 | 0.9459 | 1 |
Loa Loa (eye worm) | vps4b-prov protein | 0.0064 | 0.0035 | 0.0062 |
Trypanosoma cruzi | metalloprotease, putative | 0.0064 | 0.0035 | 0.0000043848 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0733 | 0.5655 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0517 | 0.3839 | 0.3817 |
Trypanosoma cruzi | katanin, putative | 0.0064 | 0.0035 | 0.0000043848 |
Trichomonas vaginalis | 26S protease regulatory subunit S10b, putative | 0.0295 | 0.1978 | 0.195 |
Trypanosoma cruzi | vesicular transport protein (CDC48 homologue), putative | 0.0064 | 0.0035 | 0.0000043848 |
Trypanosoma cruzi | katanin, putative | 0.0064 | 0.0035 | 0.0000043848 |
Brugia malayi | vesicle-fusing ATPase | 0.0733 | 0.5655 | 1 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.1186 | 0.9459 | 1 |
Brugia malayi | SAP1 protein | 0.0064 | 0.0035 | 0.0062 |
Toxoplasma gondii | cell division protein CDC48CY | 0.125 | 1 | 1 |
Trypanosoma cruzi | vacuolar protein sorting-associated protein 4, putative | 0.0064 | 0.0035 | 0.0000043848 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 12.5893 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 17.7828 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.